Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update
ZUG, Switzerland, Aug. 27, 2024 ( GLOBE NEWSWIRE ) -- Oculis Holding AG ( Nasdaq: OCS. XICE: OCS ) ( "Oculis" or the "Company" ) , a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced results for the quarter ended June 30, 2024, and provided ...
| Ticker |
Sentiment |
Impact |
|
AON
|
Neutral
|
18 %
|
|
OCS
|
Somewhat Bullish
|
60 %
|
